Fig. 1From: Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancerProgression-free survival (PFS) using endocrine therapy. a The PFS when aromatase inhibitors (AIs) are used first line. b The PFS with the use of front-line CDK4/6 inhibitorsBack to article page